STEFANIE KLEINLE: Open Payments
NPI 1023720174 · EL RENO, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $190 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Lundbeck LLC | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: CAPLYTA, REXULTI, VOQUEZNA, FANAPT, DUPIXENT, BREZTRI, Veozah, XIFAXAN.
Industry payments across OK — which companies pay providers there.
